Cargando…
Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation?
Cases of cardiac arrest after administration of neostigmine as a neuromuscular reversal agent have been reported in the literature. Sugammadex is a new neuromuscular reversal agent that acts via a different mechanism than acetylcholinesterase inhibitors. Here we reviewed the currently available lite...
Autores principales: | Yuki, Koichi, Scholl, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007180/ https://www.ncbi.nlm.nih.gov/pubmed/32039284 |
Ejemplares similares
-
Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017) -
Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021) -
An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023) -
Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
por: Martinez-Ubieto, J., et al.
Publicado: (2021) -
Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)